CO6450625A2 - Sistema intrauterino para uso en tratamiento médico - Google Patents
Sistema intrauterino para uso en tratamiento médicoInfo
- Publication number
- CO6450625A2 CO6450625A2 CO11150252A CO11150252A CO6450625A2 CO 6450625 A2 CO6450625 A2 CO 6450625A2 CO 11150252 A CO11150252 A CO 11150252A CO 11150252 A CO11150252 A CO 11150252A CO 6450625 A2 CO6450625 A2 CO 6450625A2
- Authority
- CO
- Colombia
- Prior art keywords
- framework
- reservoir
- intrauterine
- intrauterine system
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/26—Means for inserting tampons, i.e. applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
- A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
- A61F6/14—Contraceptive devices; Pessaries; Applicators therefor for use by females intra-uterine type
- A61F6/142—Wirelike structures, e.g. loops, rings, spirals
- A61F6/144—Wirelike structures, e.g. loops, rings, spirals with T-configuration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49826—Assembling or joining
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona un sistema intrauterino de uso en el tratamiento de enfermedades intrauterinas. El sistema consta de un depósito de una dosis terapéuticamente eficaz de un compuesto biológicamente activo, un armazón que define un espacio interior para la recepción del depósito, el armazón con una estructura abierta que permite el acceso a una parte sustancial de la superficie exterior del depósito, y uno o más elementos de retención para retener el armazón dentro del útero de un mamífero hembra, preferiblemente un ser humano. Una parte sustancial de la superficie exterior del depósito está directamente expuesta al medio ambiente y una vez que el armazón se define, las formulaciones farmacológicas existentes o cápsulas/fibras de liberación controlada se pueden insertar en el armazón. El presente invento se refiere también a un método para la fabricación de un sistema intrauterino que comprende la formación de un armazón que tiene un espacio interior y una estructura abierta, proporcionando un depósito de una dosis terapéuticamente eficaz de un compuesto biológicamente activo para el tratamiento de una condición médica.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09159353 | 2009-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6450625A2 true CO6450625A2 (es) | 2012-05-31 |
Family
ID=40943385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO11150252A CO6450625A2 (es) | 2009-05-04 | 2011-11-04 | Sistema intrauterino para uso en tratamiento médico |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8568374B2 (es) |
| EP (1) | EP2427154A1 (es) |
| JP (1) | JP5555766B2 (es) |
| KR (1) | KR20120020151A (es) |
| CN (1) | CN102438562B (es) |
| AU (1) | AU2010244494B2 (es) |
| BR (1) | BRPI1016147A2 (es) |
| CA (1) | CA2760171A1 (es) |
| CO (1) | CO6450625A2 (es) |
| IL (1) | IL215842A (es) |
| MX (1) | MX2011011748A (es) |
| MY (1) | MY179350A (es) |
| NZ (1) | NZ596005A (es) |
| RU (1) | RU2529477C2 (es) |
| WO (1) | WO2010128004A1 (es) |
| ZA (1) | ZA201107862B (es) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8961498B2 (en) * | 2008-06-25 | 2015-02-24 | Medimetrics Personalized Drug Delivery | Electronic pill comprising a plurality of medicine reservoirs |
| FI20080523A0 (fi) | 2008-09-17 | 2008-09-17 | Bayer Schering Pharma Oy | Insertteri |
| WO2010031902A1 (en) | 2008-09-17 | 2010-03-25 | Bayer Schering Pharma Oy | An inserter |
| FI20080524A0 (fi) | 2008-09-17 | 2008-09-17 | Bayer Schering Pharma Oy | Insertteri |
| JP5497176B2 (ja) | 2009-08-12 | 2014-05-21 | コーニンクレッカ フィリップス エヌ ヴェ | 圧縮可能な薬品貯槽を備える薬品送出装置 |
| JP5992330B2 (ja) * | 2009-09-29 | 2016-09-14 | メディメトリクス ペルソナリズド ドルグ デリヴェリー ベー ヴェ | 物質を投与するための子宮内電子カプセル |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| LT2782584T (lt) | 2011-11-23 | 2021-09-10 | Therapeuticsmd, Inc. | Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| CN104661622B (zh) * | 2012-08-09 | 2016-11-16 | 米斯拉制药公司 | 子宫内装置 |
| US9339364B2 (en) * | 2012-10-10 | 2016-05-17 | The Procter & Gamble Company | Intravaginal device withdrawal assembly |
| TWI669134B (zh) * | 2012-12-14 | 2019-08-21 | 法商Ｈｒａ實驗製藥股份有限公司 | 銅子宮內系統 |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20160235583A1 (en) * | 2013-02-21 | 2016-08-18 | The Procter & Gamble Company | Intravaginal device withdrawal assembly |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| DK3250183T3 (da) * | 2015-01-30 | 2024-07-22 | Ligalli B V | Vaginal lægemiddeltilførselsanordning |
| US20180140640A1 (en) | 2015-04-22 | 2018-05-24 | Cadens Beheer B.V. | Improved contraceptive methods and compositions and devices for use therein |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| KR101851737B1 (ko) * | 2016-04-26 | 2018-04-24 | 주식회사 엔도비전 | 자궁경부 유착 방지 장치 |
| FR3078486B1 (fr) * | 2018-03-01 | 2021-01-22 | Steve Eisenhut | Dispositif hygienique |
| ES1217271Y (es) * | 2018-07-24 | 2018-12-05 | Font Caselles Ramon | Aplicador de tampones |
| US20220395456A1 (en) * | 2019-11-12 | 2022-12-15 | Poly-Med, Inc. | Contraceptive medical devices |
| TW202131879A (zh) * | 2020-01-24 | 2021-09-01 | 芬蘭商拜耳股份有限公司 | 具備鎖定部件之子宮內系統 |
| US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3656483A (en) * | 1970-01-15 | 1972-04-18 | Biolog Concepts Inc | Intrauterine medicator |
| US4188951A (en) * | 1972-08-17 | 1980-02-19 | Alza Corporation | Intrauterine system embracing selected copolymeric membranes for administering beneficial agent |
| US4102998A (en) | 1972-10-02 | 1978-07-25 | Morton Gutnick | Process for the prevention of venereal disease |
| NL173707C (nl) | 1974-02-14 | 1984-03-01 | Multilan Sa | Samenstel van intra-uterine anticonceptiemiddel en bijbehorende inbrenghuls. |
| US4341728A (en) | 1979-12-20 | 1982-07-27 | The Population Council, Inc. | Method for making an IUD with shrinking of a medicated attachment onto a support |
| FR2577797A1 (fr) * | 1985-02-22 | 1986-08-29 | Benardin Henri | Dispositif de contraception feminine |
| DE4125575C2 (de) | 1991-08-02 | 1997-10-02 | Piening Wolf Dietrich Dr Med | Intrauterinpessar |
| FI97944C (fi) * | 1994-07-05 | 1997-03-25 | Leiras Oy | Vaikuttavaa ainetta luovuttava laite |
| IL123813A0 (en) * | 1997-04-11 | 1998-10-30 | Akzo Nobel Nv | Drug delivery system for two or more active substances |
| US6476079B1 (en) * | 1999-12-23 | 2002-11-05 | Leiras Oy | Devices for the delivery of drugs having antiprogestinic properties |
| BE1014635A3 (es) * | 2002-02-12 | 2004-02-03 | Wildemeersch Dirk | |
| EP1400258A1 (en) | 2002-09-18 | 2004-03-24 | Schering Oy | Pharmaceutical composition delivery device and its manufacturing process |
| GB0307082D0 (en) | 2003-03-27 | 2003-04-30 | Gyne Ideas Ltd | Drug delivery device and method |
| EP1620060B1 (en) * | 2003-04-29 | 2010-03-24 | The General Hospital Corporation | Methods and devices for the sustained release of multiple drugs |
| FR2881046A1 (fr) | 2005-01-25 | 2006-07-28 | 7 Med Ind Sa | Procede de fabrication d'un reservoir contenant une substance active diffusant a travers le reservoir et installation pour sa mise en oeuvre |
| NZ543314A (en) * | 2005-10-28 | 2007-08-31 | Interag | A delivery system where the driving substance contains the active component |
| TW200930343A (en) * | 2007-09-21 | 2009-07-16 | Organon Nv | Drug delivery system |
| EP2057972A1 (en) | 2007-11-07 | 2009-05-13 | N.V. Organon | Intrauterine deposit |
-
2010
- 2010-04-29 US US12/770,105 patent/US8568374B2/en active Active
- 2010-05-03 EP EP10715875A patent/EP2427154A1/en not_active Withdrawn
- 2010-05-03 KR KR1020117028872A patent/KR20120020151A/ko active IP Right Grant
- 2010-05-03 MY MYPI2011005242A patent/MY179350A/en unknown
- 2010-05-03 WO PCT/EP2010/055948 patent/WO2010128004A1/en active Application Filing
- 2010-05-03 JP JP2012507785A patent/JP5555766B2/ja not_active Expired - Fee Related
- 2010-05-03 AU AU2010244494A patent/AU2010244494B2/en not_active Ceased
- 2010-05-03 CA CA2760171A patent/CA2760171A1/en not_active Abandoned
- 2010-05-03 RU RU2011149223/14A patent/RU2529477C2/ru not_active IP Right Cessation
- 2010-05-03 MX MX2011011748A patent/MX2011011748A/es active IP Right Grant
- 2010-05-03 NZ NZ596005A patent/NZ596005A/xx not_active IP Right Cessation
- 2010-05-03 BR BRPI1016147A patent/BRPI1016147A2/pt not_active IP Right Cessation
- 2010-05-03 CN CN201080019981.4A patent/CN102438562B/zh not_active Expired - Fee Related
-
2011
- 2011-10-23 IL IL215842A patent/IL215842A/en not_active IP Right Cessation
- 2011-10-27 ZA ZA2011/07862A patent/ZA201107862B/en unknown
- 2011-11-04 CO CO11150252A patent/CO6450625A2/es not_active Application Discontinuation
-
2013
- 2013-11-06 US US14/036,252 patent/US20140296833A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140296833A1 (en) | 2014-10-02 |
| US8568374B2 (en) | 2013-10-29 |
| NZ596005A (en) | 2013-02-22 |
| CN102438562B (zh) | 2014-11-26 |
| AU2010244494B2 (en) | 2014-03-06 |
| JP2012525861A (ja) | 2012-10-25 |
| AU2010244494A1 (en) | 2011-11-17 |
| EP2427154A1 (en) | 2012-03-14 |
| MY179350A (en) | 2020-11-04 |
| ZA201107862B (en) | 2012-09-26 |
| BRPI1016147A2 (pt) | 2016-04-19 |
| MX2011011748A (es) | 2011-12-08 |
| IL215842A (en) | 2013-02-28 |
| CN102438562A (zh) | 2012-05-02 |
| RU2011149223A (ru) | 2013-06-10 |
| RU2529477C2 (ru) | 2014-09-27 |
| WO2010128004A1 (en) | 2010-11-11 |
| KR20120020151A (ko) | 2012-03-07 |
| CA2760171A1 (en) | 2010-11-11 |
| US20100280464A1 (en) | 2010-11-04 |
| IL215842A0 (en) | 2012-01-31 |
| JP5555766B2 (ja) | 2014-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6450625A2 (es) | Sistema intrauterino para uso en tratamiento médico | |
| AR081113A1 (es) | Liberacion pulsatil de medicamentos desde un tapon de punctum | |
| BR112015022433A2 (pt) | dispositivos de liberação de droga com componente permeável à droga e métodos | |
| CU23923B1 (es) | Polipéptidos derivados de la il-2 con actividad agonista | |
| MX2021004546A (es) | Composiciones de suministro de farmaco implantables y metodos de uso de las mismas. | |
| PH12014502516A1 (en) | Formulations and methods for vaginal delivery of antiprogestins | |
| CL2014001029A1 (es) | Forma de dosificacion farmaceutica solida oral de liberacion extendida que comprende una formulacion matricial que comprende un agente activo en forma de comprimido o multiparticulado; agente activo es un analgesico opioide; y uso en el tratamiento del dolor. (div. sol. 499-2012). | |
| BR112013005492A2 (pt) | dispositivos de implante capilares | |
| CU20150163A7 (es) | DERIVADOS DE 5-HETEROARIL-4-FENIL-4,5-DIHIDROPIRROLO(3,4-c)PIRAZOL-6-ONA ACTIVOS COMO INHIBIDORES DE BET | |
| PE20142239A1 (es) | Sistemas intrauterinos, dispositivos de insercion diu, y metodos relacionados y kits de los mismos | |
| BR112014031914A2 (pt) | cápsula de estradiol solúvel para inserção vaginal | |
| CL2011003065A1 (es) | Formulacion vesicular que comprende uno o mas fosfolipidos y uno o mas surfactantes no ionicos, libre de cualquier agente farmaceuticamente activo, util para el tratamiento del dolor asociado con osteoartritis. | |
| UY35091A (es) | Formulaciones de liberacion modificada para oprozomib | |
| BR112015029894A2 (pt) | forma de dosagem farmacêutica sólida | |
| AR080096A1 (es) | Tratamiento combinado de cancer de pancreas con gemcitabina y masitinib | |
| PE20061390A1 (es) | Formulaciones de acido hidroxamico suberoilanilida y procedimientos para la produccion de las mismas | |
| AR079000A1 (es) | Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas | |
| ECSP12012360A (es) | Preparación recubierta con partículas finas | |
| PE20110925A1 (es) | Formulacion galenica que comprende alisquireno y proceso para su preparacion mediante granulacion de extrusion fundida | |
| AR074246A1 (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento de trastornos del sueno | |
| HN2011002258A (es) | Composicion farmacéutica oral para uso en enfermedades respiratorias nuevo titulo tecnico: composición farmacéutica oral que contiene loratadina y fenilefrina. ( a petición de la oficina) | |
| MY182801A (en) | Compound for activating ampk and uses thereof | |
| CL2016002655A1 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
| TN2015000156A1 (en) | Dispersible tablet | |
| AR093707A1 (es) | Comprimido masticable que comprende un inhibidor de la fosfodiesterasa-5 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |